AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BioFish Holding AS

Investor Presentation Feb 28, 2025

3558_rns_2025-02-28_f6770baa-db7c-4260-88e7-51e5e076876e.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

4Q 2024 Presentation

28 February 2025

Acquisition of Biofish Land AS completed, securing Highlights Q4 & FY 2024

  • smolt deliveries and volume growth on track
  • Planned operational and organisational improvements nearing completion
  • Strong biological performance in facility and highquality on delivered smolt
    • One customer site, with smolt from BioFish, nominated "best performing site" of the year
  • full ownership of the land where the facility is located salmon farmers - all returning customers Sufficiently financed for planned operations and
  • Multiple long-term agreements secured with top-tier
  • investments, with no need for capital raising

Subsequent events

  • Strategic process initiated to explore growth opportunities
    • Updates on outcomes expected towards the end of Q2 2025
  • Milestone agreement secured in Q1 2025, bringing order backlog to 720 tons per year for 2025-2027
    • Secures strong sales visibility
    • Provides some capacity to take on new orders in a strong market
  • 1,693,608 warrants exercised in the fourth exercise period, generating net proceeds of NOK 1.9 million

Ramp-up in sales and strong sales visibility

  • BioFish delivered 523 tons smolt in 2024, in line with guidance of ~500-550 tons
  • New sales agreement secures ~1.2 million postsmolt deliveries annually for 2026 and 2027, with an avg. weight of 600 grams
  • The agreement includes intent to discuss additional deliveries
  • Approximately two thirds of annual volumes sold for 2025, with capacity for new orders in a strong market

Annual smolt deliveries (tons)

Ongoing strategic review process

  • A strategic review process was announced on 13 January 2025
  • Ambition is to explore growth opportunities and/or increase shareholder value
  • The process will not require capital raising
  • The strategic process is ongoing and progressing as planned
  • Pareto Securities engaged as a financial advisor
  • Updates will be provided by the end of Q2 2025

Ideal site for robust and healthy smolt

  • Strategically located RAS facility in Ljones, Western Norway, in a region with high farming density (P03)
  • Strong demand for flexible MAB utilisation, due to the "traffic light system" from the Norwegian Directorate of Fisheries
  • Water temperature and high salmon farming density in the region create demand for robust smolt and postsmolt
  • High farming density allows shorter transport to sea sites, benefiting fish health and logistics
  • The region offers good access to highly skilled and experienced workforce

Our place in the value chain

Our production

Financial highlights

  • Smolt deliveries of 155 tons, generated revenues of MNOK 12.2, compared to no sales volume in Q4-23
  • Higher opex mainly due to sales volume in the quarter
  • Reduced interest capitalisation led to higher net financial costs
  • Higher YoY sales volume, but increased costs from operational upgrades led to a larger net loss
    • 2024 sales negatively impacted by phasing of deliveries into 2025
  • Reduced long-term interest-bearing debt YoY, with a solid equity ratio of ~70%
  • Full-year 2024 capex for facility upgrades ended at MNOK 7.7, in line with guidance of MNOK 8-10
  • Facility upgrades nearing completion, with no major capex planned in 2025

Key figures in Q4 2024

9

Warrants

  • 82,550,000 warrants issued in January 2023, with 3-year duration
  • Exercise periods: Jan/Feb and Jul/Aug each year
  • Strike prices: NOK 1.10 per share (2023/ 24), NOK 1.20 per share (2024/25), NOK 1.30 (2025/26)
  • 68,714,942 warrants outstanding pr. 31.12
    • NOK 84 million potential net proceeds
  • Fourth exercise period ended 17 February 2025, with 1,693,608 warrants exercised in this period
    • Proceeds of NOK 1.9 million in total, net of expenses
  • Next exercise period will be in July/ August 2025 with a strike price of NOK 1.30 per share

Key figures

Key takeaways and outlook

  • Prime location in a high-density farming region with strong demand for MAB optimisation
  • Operational improvements and strategic review process are on track
  • Strong contract backlog with ~two-thirds of 2025 capacity already sold
  • Strong track-record, backed by positive customer feedback from top-tier salmon farmers
  • Sufficiently financed for planned operations and investments, with no need for capital raising
  • Solid growth ahead, with 2025 volume guidance of 900-1,100 tons reiterated
  • Improved cash position, positive cash flow and net profits expected from Q1 2025 onwards

11

Appendix

Income statement

Income statement
Q4 24 Q4 23 FY 24 FY 23
Total revenue 12 225 - 48 890 47 684
Cost of goods sold 11 256 1 626 34 877 37 330
Salaries and personnel expenses 3 638 4 119 15 091 7 564
Other operating expenses 2 618 2 772 8 793 6 696
Total operating expenses 17 512 8 517 58 761 51 590
Operating result (EBITDA) -5 288 -8 517 -9 870 -3 906
Depreciation 3 179 3 000 12 693 6 250
Operating result (EBIT) -8 467 -11 517 -22 563 -10 156
Net interest expenses -1 979 -1 583 -7 031 -1 770
Net agio -27 -10 7 -399
Net financial items -2 006 -1 593 -7 024 -2 169
Result before tax -10 473 -13 110 -29 587 -12 325
- -313 - -313
Tax expense

Assets

Assets
31.12.2024
30.09.2024
31.12.2023
242 805
229 696
242 806
229 696
18 539
20 975
3 073
5 003
1 405
10 584
-
ASSETS
Total tangible fixed assets 233 546
Total non-current assets 233 546
Biological assets 11 998
Other inventories 486
Account receivables
Other receivables 1 186 1 879 11 948
3 236
410
Cash and cash equivalents 1 281
27 438
38 851
Total current assets 25 713
TOTAL ASSETS
270 244
268 547
259 259
Equity and debt
31.12.2024 30.09.2024 31.12.2023
EQUITY AND LIABILITIES
Paid in equity 235 179 227 190 212 326
Earned equity -46 966 -36 840 -17 379
Total equity 188 213 190 350 194 947
Long term debt
Loans from credit institutions
49 000 50 000 52 000
Total other long term debt 49 000 50 000 52 000
Short term debt
Bank overdraft 21 550 10 000 -
Account payables 8 698 12 567 9 253
Public duties 462 532 288
Other short-term liabilities 2 321 5 098 2 771
Total short-term debt 33 030 28 197 12 312
Total debt 82 030 78 197 64 312
TOTAL EQUITY AND DEBT 270 244 268 547 259 259

Statement of cash flows

Q4 24 Q4 23 FY 24 FY 23
17 825
6 250
7 927
50
5 228
1 770
12 087
2 209 20 529 10 431 19 143
45 630
-
7 739
3 888 13 402 45 630
4 000
-
68 986
1 770
8 355 2 583 25 822 63 216
2 826 -
27 000
1 989
-
1 557
410 28 281 1 281 2 838
-
10 473
3 179
4 366
9 179
-
3 869
1 979
-
2 151
-
7 739
-
1 000
11 550
-
215
-
1 979
-
13 110
3 000
-
4 540
3 297
1 276
1 583
-
12 035
-
-
3 888
-
-
1 000
-
-
-
1 583
-
Statement of cash flows
-
29 587
-
12 693
-
9 128
-
1 405
-
555
-
7 031
10 521
-
-
-
-
13 402
-
-
-
-
3 000
-
21 550
14 303
-
7 031
-

Talk to a Data Expert

Have a question? We'll get back to you promptly.